Novartis AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other
pharmaceutical manufacturers in Europe:
Bayer AG
of GERMANY
(2019
sales of 43.55 billion Euros [US$49.31 billion]
of which 46%
was CropScience),
GlaxoSmithKline plc
of UNITED KINGDOM
(£33.75 billion [US$42.56 billion]
of which 52%
was Pharmaceuticals), and
Sanofi S.A.
which is
based in FRANCE
(37.63 billion Euros [US$42.62 billion]
of which 68%
was Pharmaceuticals).
Sales Analysis.
Novartis reported sales of 48.29 billion Swiss Francs (US$51.48 billion)
for the
year ending
December of 2019.
This
represents
a
decrease of 7.0%
versus 2018, when the company's sales were 51.94 billion Swiss Francs.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Novartis had sales
of 48.98 billion Swiss Francs.